Event 2026

World Patient Safety Congress US 

Date: 14-15 October 2026
Location: Boston, MA

Booth: 630

About the event

The World Patient Safety Congress Europe provides a platform for discussing advancements in AI, quality assurance, and signal management to improve drug safety processes.

Our experts will present case studies on how outsourcing drug safety from protocol to patient helps improve patient safety while reducing cost and effort. Come and meet our team at the congress to network and discuss key safety processes.

Speaker session

Rethinking benefit-risk: How AI is changing lifecycle decision making

Benefit–risk assessment (BRA) makes up the heart of a marketing application for a new therapy, providing regulators with one of the most important pieces of evidence to justify an approval. As clinical trials, marketing approvals, and post-market regulatory requirements have become more complex, however, the challenges of drafting a comprehensive and accurate lifecycle benefit-risk assessment have grown. Join us to explore potential means of improving benefit-risk assessments by applying innovative statistical techniques, artificial intelligence, and deep pharmacovigilance and regulatory expertise in compiling benefit-risk assessments.

Presenters:
Sophie Besset-Dangla, VP, Head of Global Pharmacovigilance, Cencora
Lin Li, PhD, Head of Statistics & Predictive AI, Cencora
Stephen Sun, MD, MPH, VP, Pharmacovigilance, Cencora

Connect with us at the booth #630

Sophie Besset-Dangla
Vice President, Head of Global Pharmacovigilance
Stephen Sun headshot
Stephen Sun, MD, MPH
VP, Pharmacovigilance
Lin Li headshot
Lin Li, PhD
Head of Statistics & Predictive AI
Nadine Ralph headshot
Nadine Ralph
Managing Director, Commercial Global Consulting Services – Global Strategic Accounts
Paul Toscano
Director, Global Consulting Services, Global Strategic Accounts
Joanna Stevens
Vice President, Enterprise Sales, Global Strategic Accounts
Nancy Birko
Marketing Manager, Product Marketing

With team across North America, Europe, and Asia-Pacific region, we blend global reach with local expertise

3,000
Consultants worldwide
30+
Global markets covered
235+
Brands represented

Helping breakthroughs break through
 

At Cencora, we’re leading the way to a place where your life-changing therapies can soar to impossible heights. Together, let’s create healthier futures for more patients around the globe.

Related resources

Case study

Mid-sized pharma optimizes local affiliate safety operations

Cencora colleagues having a meeting seen through window

Article

Harmonizing and safeguarding global and local pharmacovigilance processes

A man and a woman are sitting at a computer and discussing what is on the monitor

Article

The brave new world of predictive AI: Redefining the benefit-risk journey

A group of doctors in a meeting

Pharmacovigilance solutions

Maximize patient safety and minimize risk throughout your product life cycle. Patient safety is a primary mandate of every health authority worldwide and we know that pharmacovigilance (PV) teams are facing growing operational challenges and resource constraints.

Meet with us at World Patient Safety Congress US

Interested in learning more? We're here to answer questions and to support your Pharmacovigilance needs. Schedule time to meet with our team at the event.
Abstracts